Delivery Order HHSN272201300002I-HHSN27200013
Ended Awarded Last action
- Contract number
- HHSN27200013
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,680,664
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2012138 Solicitation number
- Contract value 100% obligated
- $1,680,664.22 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $114,158 | |
| Funding Only Action | -$9,711 | |
| Other Administrative Action | -$31,684 | |
| Change Order | $165,968 | |
| Other Administrative Action | $0 | |
| Change Order | $129,321 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $445,044 | |
| Original award | $867,569 |
About this award
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, titled "SIMIAN VACCINE EVALUATION UNITS," was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization specializing in the development of vaccines, biologics, and other medical countermeasures.
The contract, valued at $1,680,664.22, is a Cost Plus Fixed Fee delivery order awarded under the "Simian Vaccine Evaluation Units 2013-2020" Indefinite Delivery Vehicle (IDV). This IDV supports the development of various infectious disease countermeasures, including vaccines, for NIAID. ABL, a foreign-owned, for-profit manufacturer, has extensive experience working on federal government contracts and grants related to infectious disease research and product development. The contract does not have a set-aside designation, reflecting ABL's status as a large business in the federal contracting landscape.
Quick answers
Who was awarded contract HHSN27200013?
HHSN27200013 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 17, 2015.
How much is contract HHSN27200013 worth?
The government has obligated $1,680,664 on HHSN27200013.
Is contract HHSN27200013 an order under another contract?
Yes. HHSN27200013 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract HHSN27200013 competed?
The extent of competition for HHSN27200013 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award